stockrowMaxCyte, Inc. (MXCT) vs Quanterix Corporation (QTRX)
- MaxCyte, Inc. MXCT 1.27 −3.05%
- Quanterix Corporation QTRX 2.91 +5.43%
MaxCyte, Inc. and Quanterix Corporation are both Medical Devices companies. MaxCyte, Inc. and Quanterix Corporation are of similar size ($135.2M and $130.5M). Quanterix Corporation grew revenue faster over the last twelve months: 22.0% against −13.2%. Quanterix Corporation has the higher net margin (−80.3% vs −114.8%) and the lower return on invested capital (−66.5% vs −49.2%). Across the 17 metrics below, Quanterix Corporation leads on 9 and MaxCyte, Inc. on 8.
Valuation
Profitability
| Metric | MXCT | QTRX | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.23% | 44.56% | 57.76% |
| Operating margin | (134.59%) | (99.65%) | (15.07%) |
| Net margin | (114.77%) | (80.25%) | (14.45%) |
| Free cash flow margin | (76.14%) | (53.24%) | (3.88%) |
| Return on equity | (20.39%) | (46.48%) | (10.35%) |
| Return on assets | (17.62%) | (35.41%) | (17.26%) |
| Return on invested capital | (49.23%) | (66.50%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack